39 results
POS AM
EFTR
eFFECTOR Therapeutics Inc
29 Mar 24
Prospectus update (post-effective amendment)
2:51pm
the applicable rules and regulations of the SEC and Nasdaq. Our Board has determined that Ms. Loewy is an “audit committee financial expert” as defined
PRE 14A
dp8zp
27 Apr 23
Preliminary proxy
4:06pm
DEF 14A
8wg90tg0sj6nhbyr4f
20 Apr 22
Definitive proxy
4:05pm
POS AM
wr200o2hynq0rgxsfu
17 Mar 22
Prospectus update (post-effective amendment)
7:18pm
POS AM
hhrqojsgeeux9hgzf8m
17 Mar 22
Prospectus update (post-effective amendment)
7:11pm
424B3
0blbzyatb
2 Feb 22
Prospectus supplement
4:52pm
424B3
7xco0dub3w31 jklv0t
5 Oct 21
Prospectus supplement
4:24pm
8-K/A
EX-99.4
wqfm1 dulhzf1y5zy6z
31 Aug 21
Changes in Registrant's Certifying Accountant
4:38pm
8-K
EX-99.4
k2dze4nd
31 Aug 21
Entry into a Material Definitive Agreement
4:10pm
424B3
308ucdjhub1q
10 Aug 21
Prospectus supplement
5:11pm